• BH3-Mimetics and Apoptotic Sensitivity in Glioblastoma

  2026-10-06

  Koessinger and colleagues found that glioblastoma, including stem-like tumor cells, depends on the anti-apoptotic proteins BCL-xL and MCL-1 and displays increased apoptotic priming. Their study supports a context-dependent strategy in which combined targeting of these survival dependencies produces antitumor activity in preclinical models, while also highlighting the limits of translating findings from GBM models to clinical treatment.

• From Multiplexed CRISPR to Translational Evidence

  2026-10-06

  Multiplexed CRISPR can generate richer biological insight than single-target editing, but its translational value depends on evidence quality, cellular context, and control of unintended structural and stress responses. This thought-leadership article explains how 293T Cells can support early, human-cell feasibility assessments without being mistaken for a disease-relevant or clinical surrogate.

• ARB Reprogramming of Armored and Cold Tumors

  2026-10-05

  Mei et al. identify AGTR1, the target of angiotensin receptor blockers, as a vulnerability in collagen-rich, immune-excluded armored and cold tumors. Their transcriptomic, mechanistic, in vivo, cohort, and meta-analytic evidence supports a model in which ARB-associated suppression of CAF collagen production may improve response to immune checkpoint blockade, while leaving important questions about causality and clinical translation.

• GDC-0941: PI3K Inhibition and Evidence Boundaries

  2026-10-05

  GDC-0941 is a reported PI3K inhibitor with preferential biochemical activity against PI3Kα and PI3Kδ. Its relevance to PI3K/Akt pathway inhibition in liver cancer is mechanistically plausible but remains distinct from direct evidence in the DRD4-driven hepatocellular carcinoma model.

• Dimetridazole: From Virulence Biology to Translation

  2026-10-04

  Dimetridazole is emerging as a research probe for studying quorum sensing, virulence attenuation, and antibiotic potentiation in Pseudomonas aeruginosa. This evidence-led analysis separates reported findings from translational hypotheses and outlines the questions researchers should resolve before treating antivirulence activity as a development opportunity.

• Dual Enzyme-Responsive Peptides for Cancer Selectivity

  2026-10-03

  A 2026 Biomacromolecules study reports a zwitterionic peptide amphiphile that uses sequential matrix metalloproteinase-7 and cathepsin B responses to control intracellular self-assembly. The design achieved a reported cancer selectivity index of 64.1 and tumor regression in an HT-29 xenograft model, while the available evidence remains limited to defined experimental systems rather than clinical application.

• Nelfinavir Mesylate at the HIV–Ferroptosis Interface

  2026-10-02

  Nelfinavir Mesylate is best known as an orally bioavailable HIV-1 protease inhibitor, but recent evidence positions it as a useful pharmacological bridge between viral maturation, DDI2–NFE2L1 proteostasis, and ferroptosis research. This article explains how to validate target engagement, separate antiviral from proteostasis-driven effects, and translate the compound responsibly across research domains.

• Fasudil (HA-1077) HCl ROCK Workflows

  2026-10-01

  Build reproducible ROCK inhibition experiments for proliferation, migration, and apoptosis studies with a practical Fasudil workflow. The guide also shows how recent Hippo-pathway cataract research can improve assay controls without implying an unvalidated ROCK–Hippo mechanism.

• Fluorescein Tyramide: From Signal to Spatial Biology

  2026-10-01

  Fluorescein Tyramide extends tyramide signal amplification from routine staining to spatially resolved neuroscience. This article translates recent oxytocin-circuit findings into practical decisions for IHC, ISH, and quantitative tissue imaging.

• Veratridine: A Causal Map of Excitotoxicity

  2026-09-30

  Veratridine is a voltage-gated sodium channel opener that reveals how persistent depolarization becomes excitotoxic injury. This article translates landmark cortical-culture findings into a practical framework for sodium channel dynamics research and blocker-screening assay design.

• AGTR1 Blockade Reprograms Cold Tumors for ICB

  2026-09-30

  The reference study identifies AGTR1 as a stromal therapeutic target in collagen-rich, immune-excluded tumors and shows that angiotensin receptor blockade can remodel the tumor microenvironment to improve immune checkpoint blockade. Its main contribution is linking cancer-associated fibroblast signaling, collagen deposition, and clinical medication-use data in a unified framework.

• Artesunate in Cancer Assays: Beyond Viability

  2026-09-29

  Artesunate is an artemisinin derivative whose cancer activity can be misread when growth inhibition and cell death are treated as the same endpoint. This guide translates a validated viability framework into an assay strategy for ferroptosis-linked, AKT/mTOR-associated cancer research.

• Veratridine: Sodium Channel Opener Research Guide

  2026-09-29

  Veratridine is a voltage-gated sodium channel opener that maintains channel activity and produces persistent membrane depolarization. This guide separates established product specifications, reported UBXN2A findings, sodium channel dynamics research uses, and the limits of extrapolating these findings to cardiomyocyte models.

• Mifepristone (RU486): Applied Research Workflows

  2026-09-28

  Mifepristone (RU486) provides a practical, receptor-directed way to interrogate progesterone signaling in cancer, reproductive biology, and tissue models. This guide combines concentration planning, assay stratification, reference-informed controls, and troubleshooting for more reproducible results.

• Nonselective β-Blockers and HCT Recovery

  2026-09-28

  A mouse and human study links nonselective β-adrenergic blockade after hematopoietic cell transplantation to impaired blood-cell recovery, while β1-selective blockade did not show the same pattern. The findings connect adrenergic signaling in bone marrow to transplant outcomes and highlight the importance of receptor selectivity when interpreting research and clinical observational data.

8222 records 1/549 page Next 12345 下5页 Last page